Bupropion HCL ER
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
National Contract SPE2D2-23-D-0002 is an award between the Defense Logistics Agency Troop Support and Radha Pharmaceuticals Inc. for the supply of Bupropion HCL ER tablets in 150 MG and 300 MG dosages. Effective October 6, 2022, the total award amount is 23,278,523.95 dollars. The contract is managed by the DLA Troop Support Medical Supply Chain FSGB in Philadelphia, Pennsylvania, with performance taking place in Hauppauge, New York. The contract has been extended through multiple modifications to exercise option years, with the most recent action, Modification P00010, extending the period of performance through October 5, 2027. Key administrative updates include the incorporation of the Federal Acquisition Supply Chain Security Act, Drug Supply Chain Security Act labeling requirements for unit-of-use packaging, and various DoD Class Deviations regarding sustainability and equal employment opportunity. Additionally, Modification P00009 incorporated clause 52.222-90 regarding DEI discrimination by federal contractors.
General Info
Contract Value
$0Place of Performance
Hauppauge, NY, 11788, USASet-Aside
Awardee
RADHA PHARMACEUTICALS INCAward Issued Date
Documents
11AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract.
Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).
Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.
Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation.
Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract.
Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → DLA Troop Support
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
